Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,954 | -19,562 | -14,901 | -10,504 | -5,093 |
| Depreciation Amortization | 19 | 136 | 115 | 83 | 42 |
| Accounts receivable | N/A | -50 | -50 | -50 | N/A |
| Accounts payable and accrued liabilities | 566 | 1,357 | 580 | -50 | 500 |
| Other Working Capital | 1,204 | 714 | 358 | 158 | 647 |
| Other Operating Activity | -412 | -607 | -19 | 475 | -141 |
| Operating Cash Flow | $-4,577 | $-18,012 | $-13,917 | $-9,888 | $-4,045 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-1 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,883 | 17,884 | 17,884 | 17,884 | 17,884 |
| Other Financing Activity | -2,964 | -1,869 | -1,869 | -1,869 | -1,869 |
| Financing Cash Flow | $27,919 | $16,015 | $16,015 | $16,015 | $16,015 |
| Exchange Rate Effect | 45 | 412 | 391 | 348 | 501 |
| Beginning Cash Position | 2,490 | 4,076 | 4,076 | 4,076 | 4,076 |
| End Cash Position | 25,877 | 2,490 | 6,565 | 10,551 | 16,547 |
| Net Cash Flow | $23,387 | $-1,586 | $2,489 | $6,475 | $12,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,577 | -18,012 | -13,917 | -9,888 | -4,045 |
| Capital Expenditure | N/A | -1 | N/A | N/A | N/A |
| Free Cash Flow | -4,577 | -18,013 | -13,917 | -9,888 | -4,045 |